Today’s conventional Western physician typically treats an ill patient with a targeted treatment plan that focuses on the patient’s current state of health rather than the body’s inherent dynamic responses to treatment and healing. Bioregulatory Systems Medicine (BrSM) offers an alternative approach.
In April 2013, the Institute collaborated with Heel, one of the world’s leading developers of modern homeopathic medications, to hold a two-day think tank on BrSM at the Institute’s headquarters. It brought together 20 clinical, diagnostic, and scientific experts from around the world to explore ways of classifying patients’ auto-regulatory status.
The BrSM paradigm describes a novel clinical approach that leverages the body’s internal mechanisms to maintain and regain health. Drawing from new research advances in genomics and systems biology, the BrSM approach paves the way for a future of medicine that’s cost-effective, patient-centered, and better able to achieve optimal health outcomes.
For BRM to become more widely-adopted, clinicians need global, standardized ways to describe and evaluate patients’ autoregulatory status. With that in mind, the think tank sought to define states of the autoregulatory system that can serve both as a therapeutic guide and as a starting point for developing diagnostic tools and techniques.
In August 2015, a landmark paper introducing Bioregulatory Systems Medicine (BrSM), was published in Frontiers in Physiology as a result of the forum and follow-on meetings in Europe. Additionally, a presentation narrated by Institute President Brian Berman was also produced as a result of this forum.
